• Entresto

    PI ENTRESTO™ is indicated as a second-line therapy, replacing ACE inhibitors or ARBs for treatment of symptomatic heart failure (NYHA class II-IV) in patients with systolic dysfunction

  • Jalra

    PI JALRA is indicated as an adjunct to diet and exercise to improve glycaemic control in adult patients with type 2 diabetes mellitus, as add-on therapy, in combination with metformin, a sulphonylurea (SU), or insulin

  • Ritalin

    PI Ritalin (MPH) is a mild central nervous system stimulant that inhibits dopamine and noradrenaline (norepinephrine) reuptake into presynaptic neurons...
page 

Pages

 of  8
×

Medical Information Request

×

Ask Speakers